Early research (Phase 1)UnknownNCT02928211
What this trial is testing
Aftobetin-HCl and Fluorescence Detection Measured by Sapphire II to Determine the Number and Timing of Administrations
Who this might be right for
Mild Cognitive ImpairmentAlzheimer's Disease
Cognoptix, Inc. 105